跳至主要内容
临床试验/IRCT2017082225160N11
IRCT2017082225160N11招募中未知

Assessment of effect of different doses of buprenorphine (16,32 mg) on reduction of anxiety level and craving in opioid dependents

Vice chancellor of Shiraz University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 60 years(—)
性别
Male

入选标准

  • Inclusion Criteria: age between 16 to 60 y/o; informed consent; Opioid dependence Exclusion criteria:Patients unwilling to participate at beginning or during the study; use of other substances except Opioid as of the main substance

排除标准

  • 未提供

研究者

发起方
Vice chancellor of Shiraz University of Medical Sciences

相似试验